Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector

被引:14
作者
Jiang, Wenzheng
Jin, Ningyi [1 ]
Cui, Shufang
Li, Zijian
Zhang, Lishu
Wang, Hongwei
Han, Wenyu
机构
[1] Acad Mil Med Sci, Genet Engn Lab PLA, Changchun 130062, Peoples R China
[2] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China
[3] Second Mil Med Univ PLA, Expt Anim Ctr, Shanghai 200433, Peoples R China
关键词
HIV-1; gag; gpl20; IL-6; DNA vaccine; immune response;
D O I
10.1016/j.jviromet.2006.01.020
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
DNA vaccines have a demonstrated ability to induce humoral and cellular immune responses in animal models and humans. To analyze the immunogenicity of HIV-1 DNA vaccine which expressing the chimeric gene gag-gp120 of Chinese prevalent HIV-1 strain and the immunoregulatory activity of IL-6, DNA vaccine plasmid pVAX1-gag-gp120 and eukaryotic expression plasmid pVAX1-IL6 were constructed and the expression in vitro was detected by RT-PCR and Western blotting, the results showed that the gene of interest expressed in the transfected HeLa cells. To explore the immune response in mice coinoculated with HIV-1 DNA vaccine and IL-6 expression plasmid, BALB/c mice were injected i.m. with eukaryotic expression plasmid pVAX1-IL6 and DNA vaccine plasmid pVAX1-gag-gp120. The specific humoral and cellular immunity in mice could be induced by inoculating separately HIV-1 DNA vaccine plasmid or comoculating with IL-6 expression plasmid, and the specific killing activities of spleen CTL and the level of serum antibodies in the coinoculation group were significantly higher than those in the separate inoculation group. These results strongly support the use of IL-6 as a cytokine adjuvant in DNA vaccination. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 42 条
[1]   Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF [J].
Barouch, DH ;
Santra, S ;
Tenner-Racz, K ;
Racz, P ;
Kuroda, MJ ;
Schmitz, JE ;
Jackson, SS ;
Lifton, MA ;
Freed, DC ;
Perry, HC ;
Davies, ME ;
Shiver, JW ;
Letvin, NL .
JOURNAL OF IMMUNOLOGY, 2002, 168 (02) :562-568
[2]   Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [J].
Boyer, JD ;
Ugen, KE ;
Wang, B ;
Agadjanyan, M ;
Gilbert, L ;
Bagarazzi, ML ;
Chattergoon, M ;
Frost, P ;
Javadian, A ;
Williams, WV ;
Refaeli, Y ;
Ciccarelli, RB ;
McCallus, D ;
Coney, L ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (05) :526-532
[3]   HIV vaccine design and the neutralizing antibody problem [J].
Burton, DR ;
Desrosiers, RC ;
Doms, RW ;
Koff, WC ;
Kwong, PD ;
Moore, JP ;
Nabel, GJ ;
Sodroski, J ;
Wilson, IA ;
Wyatt, RT .
NATURE IMMUNOLOGY, 2004, 5 (03) :233-236
[4]  
Chow YH, 1998, J IMMUNOL, V160, P1320
[5]   Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2 [J].
Chow, YH ;
Huang, WL ;
Chi, WK ;
Chu, YD ;
Tao, MH .
JOURNAL OF VIROLOGY, 1997, 71 (01) :169-178
[6]   Modulating the immune response to genetic immunization [J].
Cohen, AD ;
Boyer, JD ;
Weiner, DB .
FASEB JOURNAL, 1998, 12 (15) :1611-1626
[7]  
Conry RM, 1996, GENE THER, V3, P67
[8]   Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein [J].
Deml, L ;
Bojak, A ;
Steck, S ;
Graf, M ;
Wild, J ;
Schirmbeck, R ;
Wolf, H ;
Wagner, R .
JOURNAL OF VIROLOGY, 2001, 75 (22) :10991-11001
[9]   DNA vaccines [J].
Donnelly, JJ ;
Ulmer, JB ;
Liu, MA .
LIFE SCIENCES, 1996, 60 (03) :163-172
[10]   Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients [J].
Durali, D ;
Morvan, J ;
Letourneur, F ;
Schmitt, D ;
Guegan, N ;
Dalod, M ;
Saragosti, S ;
Sicard, D ;
Levy, JP ;
Gomard, E .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3547-3553